Phreesia is a health information services business based in the US. Phreesia shares (PHR) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $21.03 – an increase of 0.48% over the previous week. Phreesia employs 1,438 staff and has a trailing 12-month revenue of around $390 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $21.03 |
|---|---|
| 52-week range | $12.05 - $29.16 |
| 50-day moving average | $23.35 |
| 200-day moving average | $23.20 |
| Wall St. target price | $29.43 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-1.78 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $20.99 from 2024-10-11
| 1 week (2024-10-09) | 0.29% |
|---|---|
| 1 month (2024-09-16) | -14.19% |
| 3 months (2024-07-16) | -13.83% |
| 6 months (2024-04-16) | -8.74% |
| 1 year (2023-10-16) | 28.07% |
|---|---|
| 2 years (2022-10-12) | N/A |
| 3 years (2021-10-15) | 63.66 |
| 5 years (2019-10-16) | 27.9 |
| Revenue TTM | $390 million |
|---|---|
| Gross profit TTM | $171.6 million |
| Return on assets TTM | -16.64% |
| Return on equity TTM | -40.26% |
| Profit margin | -25.73% |
| Book value | $4.36 |
| Market Capitalization | $1.2 billion |
TTM: trailing 12 months
We're not expecting Phreesia to pay a dividend over the next 12 months.
Over the last 12 months, Phreesia's shares have ranged in value from as little as $12.05 up to $29.155. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Phreesia's is 0.932. This would suggest that Phreesia's shares are less volatile than average (for this exchange).
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware. .
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out the best-performing ETFs so far in 2024.
Read our beginner’s guide to trading options in the US.